Chimerix to Present at Credit Suisse 29th Annual Healthcare Conference
November 05, 2020 16:01 ET
|
Chimerix, Inc.
DURHAM, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Reports Third Quarter 2020 Financial Results and Provides Operational Update
November 05, 2020 07:00 ET
|
Chimerix, Inc.
– Completed Rolling NDA Submissions for Both BCV Tablet and Suspension Formulations as Medical Countermeasure for Smallpox – – First Patient Visit for DSTAT Phase 3 AML Study Expected in Early...
Chimerix to Report Third Quarter 2020 Financial Results and Provide an Operational Update on November 5, 2020
October 29, 2020 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix to Participate in Upcoming Investor Conferences
September 10, 2020 08:00 ET
|
Chimerix, Inc.
DURHAM, N.C., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Reports Second Quarter 2020 Financial Results and Provides Operational Update
August 10, 2020 07:00 ET
|
Chimerix, Inc.
– Completion of BCV NDA Rolling Submission Planned for Third Quarter 2020 – – Currently Enrolling Phase 2/3 Study of DSTAT in Patients with COVID-19; Phase 2 Enrollment Completion Expected in Fourth...
Chimerix to Report Second Quarter 2020 Financial Results and Provide an Operational Update on August 10, 2020
August 03, 2020 08:00 ET
|
Chimerix, Inc.
DURHAM, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer
June 22, 2020 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., June 22, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix to Present at H.C. Wainwright Virtual Fireside Chat Series
June 18, 2020 08:00 ET
|
Chimerix, Inc.
DURHAM, N.C., June 18, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix to Present at Jefferies Virtual Healthcare Conference
May 28, 2020 08:00 ET
|
Chimerix, Inc.
DURHAM, N.C., May 28, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update
May 07, 2020 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...